Literature DB >> 24658270

Pluripotency: partial reprogramming induces cancer.

Gemma K Alderton.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24658270     DOI： 10.1038/nrc3713

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation.

Authors:  Kotaro Ohnishi; Katsunori Semi; Takuya Yamamoto; Masahito Shimizu; Akito Tanaka; Kanae Mitsunaga; Keisuke Okita; Kenji Osafune; Yuko Arioka; Toshiyuki Maeda; Hidenobu Soejima; Hisataka Moriwaki; Shinya Yamanaka; Knut Woltjen; Yasuhiro Yamada
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582
  1 in total
  3 in total

1.  Inhibition of 3-phosphoinositide-dependent protein kinase 1 (PDK1) can revert cellular senescence in human dermal fibroblasts.

Authors:  Sugyun An; Si-Young Cho; Junsoo Kang; Soobeom Lee; Hyung-Su Kim; Dae-Jin Min; EuiDong Son; Kwang-Hyun Cho
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

2.  Systems biology for reverse aging.

Authors:  Kwang-Hyun Cho; Sugyun An; Junsoo Kang
Journal:  Aging (Albany NY)       Date:  2021-06-09       Impact factor: 5.682

3.  Long intergenic non-coding RNA, regulator of reprogramming (LINC-ROR) over-expression predicts poor prognosis in renal cell carcinoma.

Authors:  Manal S Fawzy; Eman A Toraih; Aya El-Wazir; Marwa M Hosny; Dahlia I Badran; Amr El Kelish
Journal:  Arch Med Sci       Date:  2019-05-17       Impact factor: 3.318
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.